BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35049202)

  • 1. Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease.
    Wang WT; Wu TC; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Leu HB; Yin WH; Wu CC; Chen JW
    Medicine (Baltimore); 2021 Dec; 100(48):e27973. PubMed ID: 35049202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcomes of statin therapy in patients with acute ischemic stroke in Taiwan: a nationwide epidemiologic study.
    Lin HC; Lin JR; Tsai WC; Lu CH; Chang WN; Huang CC; Wang HC; Kung CT; Su CM; Su YJ; Lin WC; Cheng BC; Hsu CW; Lai YR; Tsai NW
    QJM; 2019 Dec; 112(12):891-899. PubMed ID: 31350560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive statin therapy reduces intracranial hemorrhage and 1-year mortality in patients with atrial fibrillation after acute ischemic stroke: A population-based epidemiological study from Taiwan.
    Lin HC; Tsai WC; Lin JR; Chang WN; Huang CC; Wang HC; Kung CT; Su CM; Su YJ; Lin WC; Cheng BC; Lu CH; Tsai NW
    J Clin Neurosci; 2019 Nov; 69():224-229. PubMed ID: 31327589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
    Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
    J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.
    Gilliot S; Sibon I; Mas JL; Moulin T; Béjot Y; Cordonnier C; Giroud M; Odou P; Bordet R; Vivien D; Leys D;
    J Neurol; 2018 May; 265(5):1166-1173. PubMed ID: 29549467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial Hemorrhage in the TST Trial.
    Amarenco P; Kim JS; Labreuche J; Charles H; Giroud M; Lavallée PC; Lee BC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
    Stroke; 2022 Feb; 53(2):457-462. PubMed ID: 34963300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Shao QY; Wang ZJ; Ma XT; Lin XZ; Pan L; Zhou YJ
    BMC Cardiovasc Disord; 2021 Dec; 21(1):574. PubMed ID: 34852763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure.
    Sorbets E; Labreuche J; Simon T; Delorme L; Danchin N; Amarenco P; Goto S; Meune C; Eagle KA; Bhatt DL; Steg PG
    Eur Heart J; 2014 Jul; 35(26):1760-8. PubMed ID: 24616336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).
    Lemesle G; Lamblin N; Meurice T; Tricot O; Bauters C
    J Cardiol; 2017 Mar; 69(3):542-547. PubMed ID: 27283338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
    Ndrepepa G; Braun S; Schömig A; Kastrati A
    Clin Res Cardiol; 2011 Apr; 100(4):327-33. PubMed ID: 21053005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of ischaemic and haemorrhagic stroke and the association with smoking and smoking cessation: a 10-year multicentre prospective study in China.
    Tse LA; Fang XH; Wang WZ; Qiu H; Yu IT
    Public Health; 2012 Nov; 126(11):960-6. PubMed ID: 23062630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study.
    Yoo J; Jeon J; Baik M; Kim J
    Stroke Vasc Neurol; 2023 Aug; 8(4):276-283. PubMed ID: 36549762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
    Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
    Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease.
    Nardin M; Verdoia M; Negro F; Rolla R; Tonon F; De Luca G
    Eur J Clin Invest; 2020 Feb; 50(2):e13181. PubMed ID: 31659742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal insufficiency and mortality in coronary artery disease with reduced ejection fraction.
    Peng Y; Xia TL; Liu W; Huang BT; Zhao ZG; Huang FY; Zhang C; Liao YB; Chai H; Luo XL; Li Q; Xu YN; Chen C; Meng QT; Chen M; Huang DJ
    Eur J Intern Med; 2016 Apr; 29():78-87. PubMed ID: 26809866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Significant Coronary Artery Disease in Patients with Cerebral Artery Atherosclerosis.
    Roh JW; Kwon BJ; Ihm SH; Lim S; Park CS; Chang K; Chung WS; Kim DB; Kim SR; Kim HY
    Cerebrovasc Dis; 2019; 48(3-6):226-235. PubMed ID: 31825937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.